Ménière's disease

Not to be confused with Ménétrier's disease.
Ménière's disease

Classification and external resources
Specialty otolaryngology
ICD-10 H81.0
ICD-9-CM 386.0
OMIM 156000
DiseasesDB 8003
MedlinePlus 000702
eMedicine emerg/308
MeSH D008575
Orphanet 45360

Ménière's disease /mnˈjɛərz/,[1] is a disorder of the inner ear that usually affects both hearing and balance. It is characterized by episodes of vertigo and by fluctuating or permanent tinnitus and hearing loss. The condition affects people differently. It can range in intensity from being a mild annoyance to a disabling disease.

The condition is named after the French physician Prosper Ménière, who in an article from 1861 described the main symptoms and was the first to suggest as a single cause for all of them a disorder in the combined organ of balance and hearing in the inner ear.[2]

The immediate cause of Ménière's disease is endolymphatic hydrops, an excess of fluid in the inner ear. The possible causes of endolymphatic hydrops, in turn, are not well understood. For this reason a causal treatment of endolymphatic hydrops - and thus also for Ménière's disease - does not exist.

However, episodes of vertigo usually subside as the illness progresses or stabilizes, and most patients learn to manage tinnitus and hearing loss. This even applies to patients who are affected in both ears from some point in the course of their lives (ca. 30%).

Signs and symptoms

Audiograms illustrating normal hearing (left) and unilateral low-pitch hearing loss associated with Ménière's disease (right).

Ménière's is characterized by recurrent episodes of vertigo, hearing loss and tinnitus. Though it often begins with a single symptom, the disease gradually progresses. Not all symptoms must be present to confirm the diagnosis,[3] but experiencing several of the typical symptoms at once greatly increases the likelihood that a diagnosis of Ménière's is correct. The diagnosis of Ménière's disease is made only if patients complain of both episodic vertigo and episodic sensorineural hearing loss. While these symptoms could be related to a variety of ear-related illnesses, Ménière's disease is characterized by the occurrence of 2-3 symptoms at the same time, in discrete "episodes".[4] Conditions with partly similar symptoms - but no connection to Ménière's disease - include syphilis, Cogan's syndrome, autoimmune inner ear disease, dysautonomia, perilymph fistula, multiple sclerosis, acoustic neuroma, and both hypo- and hyperthyroidism.[5]

Ménière's symptoms vary. Not all sufferers experience the same symptoms. However the "classic" presentation of Ménière's has the following three symptoms:[6]

Some patients may also experience a sensation of fullness or pressure to one or both ears. They may also experience additional symptoms related to irregular reactions of the autonomic nervous system. These symptoms are not symptoms of Meniere's disease per se, but rather are side effects resulting from failure of the organ of hearing and balance, and include nausea, vomiting, and sweating—which are typically symptoms of vertigo, and not of Ménière's. Vertigo may induce nystagmus, or uncontrollable rhythmical and jerky eye movements, usually in the horizontal plane, reflecting the essential role of the non-visual input by the organ of balance in coordinating eye movements.[12]

Sudden falls without loss of consciousness (drop attacks, also known as Tumarkin attacks) may be experienced by some people, usually in the later stages of the disease.[13][14] Less than 10% of people with Ménière's disease tend to experience such attacks. There is typically a sensation of being pushed sharply to the floor from behind (this is thought to be triggered by a sudden mechanical disturbance of the otolithic membrane that activates motoneurons in the vestibulospinal tract).[15] The affected person is able to get up again immediately afterwards.[15]

Cause

Ménière's disease is linked to endolymphatic hydrops, an excess of fluid in the inner ear.[16] The membranous labyrinth, a system of membranes in the ear, contains a fluid called endolymph. In Ménière's disease, endolymph bursts from its normal channels in the ear and flows into other areas, causing damage. This accumulation of fluid is referred to as "hydrops". The membranes become dilated (stretched thin, like a balloon) when pressure increases and drainage is blocked.[17] This may be related to swelling of the endolymphatic sac or other tissues in the vestibular system of the inner ear, which is responsible for the body's sense of balance.

Ménière's disease affects about 190 people per 100,000.[18] Recent gender predominance studies show that Ménière's tends to affect women more often than men.[18] In three nationwide surveys in Japan on Ménière's disease between 1975 and 1990 the data of 958 definite Ménière cases were analyzed. Onset of the disease peaked in the forties for males and thirties for females. A higher incidence was noted "in people with a nervous and precise character".[19]

Diagnosis

Doctors establish a diagnosis with complaints and medical history. However, a detailed otolaryngological examination, audiometry, and head MRI scan should be performed to exclude a vestibular schwannoma or superior canal dehiscence, which would cause similar symptoms. Some of the same symptoms also occur with benign paroxysmal positional vertigo (BPPV), and with cervical spondylosis (which can affect blood supply to the brain and cause vertigo).

Ménière's disease is idiopathic and therefore a diagnosis of exclusion, meaning there is no definitive test for Ménière's; it is only diagnosed when all other possible causes of the patient's symptom have been ruled out.[20]

History

Ménière's disease had been recognized as early as the 1860s, but the definition was still relatively vague and broad at the time. The American Academy of Otolaryngology-Head and Neck Surgery Committee on Hearing and Equilibrium (AAO HNS CHE) set criteria for diagnosing Ménière's, as well as defining two sub categories of Ménière's: cochlear (without vertigo) and vestibular (without deafness).[21]

In 1972, the academy defined criteria for diagnosing Ménière's disease as:[22]

  1. Fluctuating, progressive, sensorineural deafness.
  2. Episodic, characteristic definitive spells of vertigo lasting 20 minutes to 24 hours with no unconsciousness, vestibular nystagmus always present.
  3. Tinnitus (ringing in the ears, from mild to severe) Often the tinnitus is accompanied by ear pain and a feeling of fullness in the affected ear. Usually the tinnitus is more severe before a spell of vertigo and lessens after the vertigo attack.
  4. Attacks are characterized by periods of remission and exacerbation.

In 1985, this list changed to alter wording, such as changing "deafness" to "hearing loss associated with tinnitus, characteristically of low frequencies" and requiring more than one attack of vertigo to diagnose.[23] Finally in 1995, the list was again altered to allow for degrees of the disease:[24]

  1. Certain - Definite disease with histopathological confirmation
  2. Definite - Requires two or more definitive episodes of vertigo with hearing loss plus tinnitus and/or aural fullness
  3. Probable - Only one definitive episode of vertigo and the other symptoms and signs
  4. Possible - Definitive vertigo with no associated hearing loss

Management

Several environmental and dietary changes are thought to reduce the frequency or severity of symptom outbreaks. It is believed that since high sodium intake causes water retention, a diet high in salt can lead to an increase (or at least prevent the decrease) of fluid within the inner ear, although the relationship between salt and the inner ear is not fully understood.[25] Thus, a low sodium diet is often prescribed, with sodium intake reduced to one to two grams of sodium per day[25] (equivalent to approximately 2.5 to 5 grams of table salt, or a little more than one third to two thirds of a teaspoon). By comparison, the recommended Upper Limit (UL) for sodium intake is 2.3 grams per day,[26] and most people are recommended to consume less than 1.5 grams,[26] but on average people in the United States consume 3.4 grams per day.[27]

Low-sodium, high-potassium dietary intake has been recommended on the basis of physiological experiments.[28] The WHO generally recommends for adults a daily potassium intake of 3.5 g.[29]

Getting adequate sleep and avoiding stress is an important aspect of managing the symptoms of Ménière's disease. Additionally, patients are advised to avoid alcohol, caffeine, and tobacco, as well as large quantities of chocolate or salt, all of which can aggravate Ménière's symptoms.[30]

Although a causal relation between allergy and Menière's disease is uncertain, it has been recommended that allergy control is part of the treatment for Menière's disease in patients with a history of seasonal or food allergy, childhood or family history of allergy, or a development of symptoms within a short time after exposure to food or inhaled allergen.[31]

In order to reduce nausea and vomiting during an episode, antihistamines such as meclizine are used.[32]

Equalizing pressure in middle and inner ear

A man performs the Valsalva maneuver, while the eardrum of his right ear is examined with an otoscope.

The systems of pressure equalization of the inner ear are coupled in a highly complex way to the permanently ongoing variations of static pressure in the air chamber in the middle ear. Importantly, the inner ear pressure equalization is activated by these middle ear pressure changes. The details of these mechanisms have been described both physiologically[33] and anatomically.[34]

Middle ear pressure is determined primarily by a slow mechanism, the gas exchange with middle ear tissues, and secondarily by a fast mechanism, the transient opening of the Eustachian tube (auditory tube) that links the nasal spaces (nasopharynx) to the middle ear. The fast mechanism is normally triggered automatically, e.g., when chewing or yawning, but it can also be started voluntarily, e.g., when flying or diving (ear clearing).

In Ménière's patients the natural pressure regulation of the middle ear is clearly worse than normal[35] and already in 1988 it was shown that additional ventilation of the middle ear could prevent Ménière's attacks.[36] In 1997 it could even be established experimentally that additional ventilation of the middle ear indeed is effective against the development and progression of endolymphatic hydrops, the pathology preceding and immediately causing Ménière's disease.[37]

The method of choice for voluntary ventilation of the middle ear is the Valsalva maneuver.[38] It can be applied nearly anywhere spontaneously and without tools and is preferably combined with a following equalization by yawning or chewing (soft plopping sound per ear). The Valsalva maneuver, which always needs to be carried out gently, leads to a short-time increase in middle ear pressure that then disappears during the following equalization. Because the procedure activates – secondarily – also the natural pressure equalization in the inner ear, as described above, it generally has positive effects against the symptoms of Ménière's disease.

Coping

Sufferers tend to have high stress and anxiety, which may be caused directly by the disease and not merely a secondary effect.[39] Vestibular injuries are known to increase levels of anxiety directly by affecting signal processing in the brain, and vice versa, i.e. anxiety negatively affects vestibular signal processing.[40][41] Some patients benefit from non-specific yoga, t'ai chi,[42] and meditation. Greenberg and Nedzelski recommend education to alleviate feelings of depression or helplessness.[25]

Surgery

If symptoms do not improve with typical treatment, more permanent surgery is considered.[43] However, because the inner ear deals with both balance and hearing, few surgeries guarantee no hearing loss.

Nondestructive surgeries include procedures that don't actively remove any functionality, but rather aim to improve the way the ear works.[44] Surgery to decompress the endolymphatic sac has shown effective for relief from symptoms. Most patients see a decrease in vertigo occurrence, while their hearing may be unaffected. In a systematic review and meta-analysis from 2014 it was reported that in at least 75% of patients with Ménière's disease it was effective at controlling vertigo in the short term (>1 yearr of follow-up) and long term (>24 months).[45]

Conversely, destructive surgeries are irreversible and involve removing entire functionality of most, if not all, of the affected ear.[46] The inner ear itself can be surgically removed via labyrinthectomy although hearing is always completely lost in the affected ear with this operation.[4] Alternatively, a chemical labyrinthectomy, in which a drug (such as gentamicin) that "kills" parts or most of the vestibular apparatus is injected into the middle ear, can accomplish the same results with a reasonable chance of retaining hearing, at least partly.[47][48]

In more serious cases surgeons can cut the nerve to the balance portion of the inner ear in a vestibular neurectomy. Hearing is often mostly preserved, however the surgery involves cutting open into the lining of the brain, and a hospital stay of a few days for monitoring would be required.[49] Vertigo (and the associated nausea and vomiting) typically accompany the recovery from destructive surgeries as the brain learns to compensate.[49]

Physical exercise

Retraining of the balance system after loss of sensory input from the vestibular system in the inner ear is essential. Almost any kind of physical activity is recommended, as soon as the immediate effects of vertigo attacks have subsided.[50]

Applications without evidence of positive effect

Prognosis

Ménière's disease usually starts confined to one ear, but it often extends to involve both ears over time. The number of patients who end up with bilaterial Ménière's was estimated on the basis of temporal bone autopsies to be ca. 30%.[56]

The impact of vertigo on the ability to work has been described as moderate. According to a Swedish study the loss of annual working days was between none and four.[57]

Hearing loss usually fluctuates in the beginning stages and becomes more permanent in later stages, although hearing aids and cochlear implants can help remedy damage.[58] Tinnitus can be unpredictable, but patients usually get used to it over time.[58]

The course of progression of Ménière's disease varies. Attacks can come more frequently and more severely, less frequently and less severely, and anywhere in between.[59] However, Ménière's has a tendency to "burn out". Once much or all of vestibular function in an ear has disappeared, distorted sensory input to the brain is no longer generated and vertigo attacks cease.

While Ménière's disease in general has no known effects on cognitive performance, vertigo is associated with a clearly increased risk of impairment in concentration and memory.[60]

Notable cases

Notes

  1. Dictionary.com Unabridged (v 1.1). Random House, Inc. Accessed on 9 September 2008
  2. Méniere (1861) "Sur une forme de surdité grave dépendant d’une lésion de l’oreille interne" (On a form of severe deafness dependent on a lesion of the inner ear), Bulletin de l'Académie impériale de médecine, 26 : 241.
  3. Hazell, Jonathan. "Information on Ménière's Syndrome". Retrieved 27 February 2007.
  4. 1 2 "Meniérè's disease". Maryland Hearing and Balance Center. Retrieved 18 December 2015.
  5. Haybach, pg. 55
  6. "Meniere's disease symptoms". Mayo Clinic. 18 June 2008. Retrieved 17 October 2008.
  7. Haybach, pg. 70
  8. Lempert, T.; Neuhauser, H. (November 2008). "Epidemiology of vertigo, migraine and vestibular migraine". Journal of Neurology 256 (3): 333–338. doi:10.1007/s00415-009-0149-2. PMID 19225823.
  9. Haybach, p. 72
  10. Haybach, p. 71
  11. Haybach, pg. 79
  12. Haybach, pg. 46
  13. Ruckenstein, MJ; Shea, JJ Jr (1999). Harris, JP, ed. Meniere's Disease. Kugler Publications. p. 266. ISBN 978-90-6299-162-4.
  14. Hayback, PJ. "Mèniére's Disease". vestibular.org. Vestibular Disorders Association. Retrieved 22 September 2015.
  15. 1 2 Harcourt J, Barraclough K, Bronstein AM (2014). "Meniere's disease". BMJ (Clinical Research Ed.) 349: g6544. doi:10.1136/bmj.g6544. PMID 25391837.
  16. Haybach, pg. 8
  17. Menieres Causes at the American Hearing Research Foundation Chicago, Illinois 2008.
  18. 1 2 Thomas, Alexander; Jeffrey Harris (October 2010). "Current Epidemiology of Menière's Syndrome". Otolaryngologic Clinics of North America 43 (5): 965–970. doi:10.1016/j.otc.2010.05.001. PMID 20713236.
  19. Y. Watanabe, K. Mizukoshi, H. Shojaku, I. Watanabe, M. Hinoki, M. Kitahara: Epidemiological and clinical characteristics of Menière's disease in Japan. In: Acta oto-laryngologica. Supplementum. Vol 519, 1995, pp. 206–210, PMID 7610869.
  20. Haybach, pg. 9
  21. Beasley, Jones, p.1111, para.elsei 3
  22. Beasley, Jones, p.1111, para. 2/table I
  23. Beasley, Jones, p.1111, para. 4/table II
  24. Beasley, Jones, p.1112, para. 2/table III
  25. 1 2 3 Greenberg, Simon; Julian Nedzelski (October 2010). "Medical and Noninvasive Therapy for Menière's Disease". Otolaryngologic Clinics of North America 43 (5): 1081–1090. doi:10.1016/j.otc.2010.05.005. PMID 20713246.
  26. 1 2 "Dietary Reference Intakes: Water, Potassium, Sodium, Chloride, and Sulfate". Food and Nutrition Board, Institute of Medicine, United States National Academies. 11 February 2004.
  27. U.S. Department of Agriculture; U.S. Department of Health and Human Services (December 2010). Dietary Guidelines for Americans, 2010 (PDF) (7th ed.). p. 22. ISBN 978-0-16-087941-8. OCLC 738512922. Retrieved 2011-11-23.
  28. W. J. ten Cate, L. M. Curtis, K. E. Rarey: Effects of low-sodium, high-potassium dietary intake on cochlear lateral wall Na+,K(+)-ATPase. In: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. Vol 251, Nr 1, 1994, pp. 6–11, PMID 8179870.
  29. WHO-Guideline: Potassium Intake for Adults and Children, 2012.
  30. Harris, Jeffrey (Ed.) (1999). Ménière's disease. The Hague: Kugler Publications. p. 343-344. ISBN 978-90-6299-162-4.
  31. H. M. Weinreich, Y. Agrawal: The link between allergy and Menière's disease. In: Current opinion in otolaryngology & head and neck surgery. Vol 22, Nr 3, June 2014, pp. 227–230, doi:10.1097/MOO.0000000000000041, PMID 24573125, PMC 4549154 (Review).
  32. Harris, Jeffrey (Ed.) (1999). Ménière's disease. The Hague: Kugler Publications. p. 344. ISBN 978-90-6299-162-4.
  33. H. P. Wit, R. A. Feijen, F. W. Albers: Cochlear aqueduct flow resistance is not constant during evoked inner ear pressure change in the guinea pig. In: Hearing research. Vol 175, Nr 1–2, January 2003, ISSN 0378-5955, pp. 190–199, PMID 12527138.
  34. R. Hofman, J. M. Segenhout, F. W. Albers, H. P. Wit: The relationship of the round window membrane to the cochlear aqueduct shown in three-dimensional imaging. In: Hearing research. Vol 209, Nr 1–2, November 2005, ISSN 0378-5955, pp. 19–23, doi:10.1016/j.heares.2005.06.004, PMID 16039079.
  35. M. Brattmo, B. Tideholm, B. Carlborg: Inadequate opening capacity of the eustachian tube in Meniere's disease. In: Acta oto-laryngologica. Vol 132, Nr 3, March 2012, ISSN 1651-2251, pp. 255–260, doi:10.3109/00016489.2011.637175, PMID 22201512.
  36. P. Montandon, P. Guillemin, R. Häusler: Prevention of vertigo in Ménière's syndrome by means of transtympanic ventilation tubes. In: ORL; journal for oto-rhino-laryngology and its related specialties. Vol 50, Nr 6, 1988, ISSN 0301-1569, pp. 377–381, PMID 3231460.
  37. R. S. Kimura, J. Hutta: Inhibition of experimentally induced endolymphatic hydrops by middle ear ventilation. In: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. Vol 254, Nr 5, 1997, ISSN 0937-4477, pp. 213–218, PMID 9195144.
  38. Alper, Cuneyt (2004). Advanced therapy in otitis media. Hamilton, Ont. Lewiston, NY: BC Decker. p. 395. ISBN 1-55009-201-4.
  39. Haybach, p. 231
  40. http://journal.frontiersin.org/Journal/10.3389/fnint.2013.00084/full
  41. "Vestibulo-ocular function in anxiety disorders.". J Vestib Res 16 (4-5): 209–15. 2006. PMID 17538210.
  42. Haybach, p. 198-200
  43. Haybach, p. 181
  44. Haybach, p.209
  45. A. J. Sood, P. R. Lambert, S. A. Nguyen, T. A. Meyer: Endolymphatic sac surgery for Ménière's disease: a systematic review and meta-analysis. In: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. Vol 35, Nr 6, Juli 2014, pp. 1033–1045, doi:10.1097/MAO.0000000000000324, PMID 24751747 (Review).
  46. Haybach, p.212
  47. B. Pullens, P. P. van Benthem: Intratympanic gentamicin for Ménière's disease or syndrome. In: The Cochrane database of systematic reviews. Nr 3, 2011, pp. CD008234, doi:10.1002/14651858.CD008234.pub2, PMID 21412917 (Review).
  48. L. K. Huon, T. Y. Fang, P. C. Wang: Outcomes of intratympanic gentamicin injection to treat Ménière's disease. In: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. Vol 33, Nr 5, Juli 2012, pp. 706–714, doi:10.1097/MAO.0b013e318259b3b1, PMID 22699980 (Review).
  49. 1 2 Haybach, p.215
  50. R. A. Clendaniel, D. L. Tucci: Vestibular rehabilitation strategies in Meniere's disease. In: Otolaryngologic clinics of North America. Vol 30, Nr 6, December 1997, pp. 1145–1158, PMID 9386249 (Review).
  51. A. L. James, M. J. Burton: Betahistine for Menière's disease or syndrome. In: The Cochrane database of systematic reviews. Nr 1, 2001, ISSN 1469-493X, pp. CD001873, doi:10.1002/14651858.CD001873, PMID 11279734 (Review).
  52. C. Adrion, C. S. Fischer, J. Wagner, R. Gürkov, U. Mansmann, M. Strupp: Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). In: BMJ (Clinical research ed.). Vol 352, 2016, pp. h6816, PMID 26797774, PMC 4721211.
  53. S. van Sonsbeek, B. Pullens, P. P. van Benthem: Positive pressure therapy for Ménière's disease or syndrome. In: The Cochrane database of systematic reviews. Vol 3, 2015, pp. CD008419, doi:10.1002/14651858.CD008419.pub2, PMID 25756795 (Review).
  54. M. I. Syed, J. A. Rutka, J. Hendry, G. G. Browning: Positive pressure therapy for Meniere's syndrome/disease with a Meniett device: a systematic review of randomised controlled trials. In: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. Vol 40, Nr 3, June 2015, pp. 197–207, doi:10.1111/coa.12344, PMID 25346252 (Review).
  55. A. Hu, L. S. Parnes: Intratympanic steroids for inner ear disorders: a review. In: Audiology & neuro-otology. Vol 14, Nr 6, 2009, pp. 373–382, doi:10.1159/000241894, PMID 19923807 (Review).
  56. Y. Yazawa, M. Kitahara: Bilateral endolymphatic hydrops in Menière's disease: review of temporal bone autopsies. In: The Annals of otology, rhinology, and laryngology. Vol 99, Nr 7 Pt 1, July 1990, pp. 524–528, PMID 2195960 (Review).
  57. Harris, Jeffrey (Ed.) (1999). Ménière's disease. The Hague: Kugler Publications. p. 27. ISBN 978-90-6299-162-4.
  58. 1 2 Haybach, pg. 223
  59. Haybach, pg. 221
  60. R. T. Bigelow, Y. R. Semenov, S. du Lac, H. J. Hoffman, Y. Agrawal: Vestibular vertigo and comorbid cognitive and psychiatric impairment: the 2008 National Health Interview Survey. In: Journal of neurology, neurosurgery, and psychiatry. Vol 87, Nr 4, April 2016, pp. 367–372, doi:10.1136/jnnp-2015-310319, PMID 25886779.
  61. Drew, Ian (21 October 2011). "Ryan Adams Opens Up About Tragic Ear Disease". US Weekly. Retrieved 25 May 2012. Having your first album of new material immediately break into the Billboard Top 200 albums chart on release week is usually cause for celebration for most rock stars. But Ryan Adams isn't smiling just because his brilliantly subdued new disc, Ashes & Fire, slid right in at #7 this week. That's because the alternative singer, 36, is still grappling with Ménière's disease, a debilitating and incurable inner ear condition that forced him to take a break from music for over two years.
  62. Byron, Ellen. "Kristin Chenoweth: Exclusive Interview With Prevention". Prevention.com. Retrieved 7 March 2013.
  63. Arenberg IK, Countryman LF, Bernstein LH, Shambaugh GE (1990). "Van Gogh had Menière's disease and not epilepsy". JAMA 264 (4): 491–3. doi:10.1001/jama.264.4.491. PMID 2094236.
  64. Arnold, Wilfred N. (1992). Vincent van Gogh: Chemicals, Crises, and Creativity. Birkhäuser Boston. ISBN 0-8176-3616-1.
  65. "Cumhurbaşkanımızın hastalığı hakkında - Prof. Dr. Osman MÜFTÜOĞLU - Hürriyet". Hurriyet.com.tr. Retrieved 7 March 2013.
  66. George Dudley Seymour Papers, Yale Manuscripts and Archives
  67. ~Doc-Hammer, 16 May 2005, 7:08:23 PM (16 May 2005). "50 Questions (from MySpace) by ~Doc-Hammer on deviantART". Doc-hammer.deviantart.com. Retrieved 7 March 2013.
  68. Feldmann H (1989). "Martin Luther's seizure disorder". Sudhoffs Archiv (in German) 73 (1): 26–44. PMID 2529669.
  69. Cawthorne, T (1947). "Ménière's disease". Annals of Otology 56: 18–38.
  70. Brown, Peter and Barham, Patte Marilyn: The Last Take. New York: Dutton, 1992, p. 221 ISBN 0-525-93485-5
  71. Alice Lagnado (2 May 2011). "Wildlife star Chris Packham on living with chronic vertigo | Mail Online". Dailymail.co.uk. Retrieved 7 March 2013.
  72. Toker, Leona (2000). Return from the Archipelago: narratives of Gulag survivors. Bloomington: Indiana University Press. p. 149. ISBN 0-253-33787-9. Meanwhile, Shalamov's health kept deteriorating—the Kolyma twig would have but a short time before wilting in Moscow. The body of a Kolyma survivor bore witness of its own: blindness, deafness, frostbitten skin, Ménière’s disease, chronic congestion, and apparently also minor strokes, angina pectoris, Parkinson's disease, and incipient dementia. Iulii Shreider found a woman to cook and clean for him, yet eventually Shalamov broke with her too. Unable to take care of himself, in 1979 he was placed in a nursing home (see Isaev 1996).
  73. Gray, Tara. "Alan B. Shepard, Jr.". 40th Anniversary of Mercury 7. NASA. Retrieved 25 May 2012.
  74. Crook, Keith (1998). A Preface to Swift. Longman. p. 6. ISBN 978-0582289789.
  75. http://www.mmamania.com/2013/2/22/4018206/ufc-dana-white-ear-surgery-menieres-disease-mma
  76. http://www.mmamania.com/2013/4/18/4240318/dana-white-meniers-disease-a-rod-germany-stem-cell-treatment-cure-ufc-president
  77. Su Yu

References

  • Harris, Jeffrey (Ed.) (1999). Ménière's disease. The Hague: Kugler Publications. ISBN 978-90-6299-162-4. 
  • Haybach, P. J. (1998). Meniere's Disease: What You Need to Know. Portland, OR: Vestibular Disorders Association. ISBN 0-9632611-1-8. 
  • Beasley NJ, Jones NS (December 1996). "Menière's disease: evolution of a definition". J Laryngol Otol 110 (12): 1107–13. doi:10.1017/S002221510013590X. PMID 9015421. 
This article is issued from Wikipedia - version of the Wednesday, May 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.